Evidence map›Paper›PMID 20421305›Full record

ArticleThe Journal of biological chemistry2010

HDAC2 promotes eIF4E sumoylation and activates mRNA translation gene specifically.

Xiang Xu, Jaya Vatsyayan, Chenxi Gao, Christopher J Bakkenist, Jing Hu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. HDAC11 Regulates RNA Splicing via De-Fatty Acylation of SF3B2.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Fusion proteins ofTranslation (Austin, Tex.) · 2016
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Xiang XuDepartment of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Jaya Vatsyayan
Chenxi Gao
Christopher J Bakkenist
Jing Hu
UPMC Hillman Cancer Center · USUniversity of Pittsburgh · US

Funding

Role of Translational Control in Anti-Cancer Effects of PEITCR21CA128681 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HU, JING · 2008 to 2009
$375k
NCI NIH HHS CA128681NCI NIH HHS R21 CA128681
6 · The paper itself

Abstract

Histone deacetylases (HDACs) are best known as transcription corepressors through deacetylating histone tails. Here we show that HDAC2 is also involved in cap-dependent mRNA translation by promoting sumoylation of eukaryotic translation initiation factor 4E (eIF4E), which is independent of its deacetylase activity. By stimulating eIF4E sumoylation, HDAC2 induces the formation of the active eukaryotic initiation factor 4F (eIF4F) complex and induces the protein synthesis of a subset of eIF4E-responsive genes that are essential for cell proliferation and preventing apoptosis. These data demonstrate that HDAC2 has an unexpected sumoylation-promoting activity and regulates cap-dependent mRNA translation.

Indexed as

Gene Expression RegulationProtein BiosynthesisApoptosisCell ProliferationCytoplasmDNA, ComplementaryEukaryotic Initiation Factor-4EGene Expression ProfilingGenes, ReporterHistone Deacetylase 2HumansLuciferasesRNA, MessengerSUMO-1 ProteinDNA, ComplementaryEukaryotic Initiation Factor-4EHDAC2 protein, humanHistone Deacetylase 2LuciferasesRNA, MessengerSUMO-1 ProteinSUMO1 protein, human

Identifiers

PMID20421305
PMCPMC2881737
OpenAlexW1574085794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.